Personalizing Pharmacotherapy

This activity, developed by family medicine and mental health clinicians, discusses team-based screening recommendations, along with strategies for overcoming barriers in diagnosis, are applied to primary care practice. The risks and benefits of treatment, including nonpharmacologic and pharmacologic options, such as selective serotonin reuptake inhibitors and neuroactive steroid gamma-aminobutyric acid A receptor positive modulators, are discussed, to enable the development of a personalized care plan using a collaborative care model.

Share Personalizing Pharmacotherapy

Sign up to save your podcasts

Personalizing Pharmacotherapy

Personalizing Pharmacotherapy